| Chul Young Chung, MD | |
|
1400 Locust St, Pittsburgh, PA 15219-5114 | |
| (412) 232-5689 | |
| Not Available |
| Full Name | Chul Young Chung |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 11 Years |
| Location | 1400 Locust St, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033552773 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | A154576 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northbay Medical Center | Fairfield, CA | Hospital |
| Regional Medical Center Of San Jose | San jose, CA | Hospital |
| Sutter Solano Medical Center | Vallejo, CA | Hospital |
| Sutter Delta Medical Center | Antioch, CA | Hospital |
| Good Samaritan Hospital | San jose, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Solano Diagnostics Partners, A Calif Limited Partnership | 4587556865 | 25 |
| Bay Imaging Consultants Medical Group Inc | 9537069125 | 132 |
News Archive
Calls for the British Government to take action on TB have been met by a wall of silence from the Department of Health. The British Thoracic Society, the British Lung Foundation and TB Alert are warning that lives are being put at risk by the Government's failure to publish the long-promised TB Action Plan.
The New York Times on Saturday examined how a recent report indicating that Merck used "ghostwriters" to produce medical journal articles in support of the COX-2 inhibitor Vioxx "has galvanized opponents to a federal proposal that would relax some restrictions on drug promotion" in the U.S.
It's better to induce than to watch and wait. That's the result of a new study published in PLOS ONE.
Christopher A. Holden, President and Chief Executive Officer of AmSurg Corp., today announced financial results for the second quarter ended June 30, 2012. Revenues for the quarter were $231.6 million, a 23% increase from $187.5 million for the second quarter of 2011.
› Verified 6 days ago
| Entity Name | University Of California Sfgh Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063487122 PECOS PAC ID: 5496668410 Enrollment ID: O20031106000503 |
News Archive
Calls for the British Government to take action on TB have been met by a wall of silence from the Department of Health. The British Thoracic Society, the British Lung Foundation and TB Alert are warning that lives are being put at risk by the Government's failure to publish the long-promised TB Action Plan.
The New York Times on Saturday examined how a recent report indicating that Merck used "ghostwriters" to produce medical journal articles in support of the COX-2 inhibitor Vioxx "has galvanized opponents to a federal proposal that would relax some restrictions on drug promotion" in the U.S.
It's better to induce than to watch and wait. That's the result of a new study published in PLOS ONE.
Christopher A. Holden, President and Chief Executive Officer of AmSurg Corp., today announced financial results for the second quarter ended June 30, 2012. Revenues for the quarter were $231.6 million, a 23% increase from $187.5 million for the second quarter of 2011.
› Verified 6 days ago
| Entity Name | John Muir Physician Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841407665 PECOS PAC ID: 6608789813 Enrollment ID: O20031226000143 |
News Archive
Calls for the British Government to take action on TB have been met by a wall of silence from the Department of Health. The British Thoracic Society, the British Lung Foundation and TB Alert are warning that lives are being put at risk by the Government's failure to publish the long-promised TB Action Plan.
The New York Times on Saturday examined how a recent report indicating that Merck used "ghostwriters" to produce medical journal articles in support of the COX-2 inhibitor Vioxx "has galvanized opponents to a federal proposal that would relax some restrictions on drug promotion" in the U.S.
It's better to induce than to watch and wait. That's the result of a new study published in PLOS ONE.
Christopher A. Holden, President and Chief Executive Officer of AmSurg Corp., today announced financial results for the second quarter ended June 30, 2012. Revenues for the quarter were $231.6 million, a 23% increase from $187.5 million for the second quarter of 2011.
› Verified 6 days ago
| Entity Name | Bay Imaging Consultants Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356597637 PECOS PAC ID: 9537069125 Enrollment ID: O20040110000189 |
News Archive
Calls for the British Government to take action on TB have been met by a wall of silence from the Department of Health. The British Thoracic Society, the British Lung Foundation and TB Alert are warning that lives are being put at risk by the Government's failure to publish the long-promised TB Action Plan.
The New York Times on Saturday examined how a recent report indicating that Merck used "ghostwriters" to produce medical journal articles in support of the COX-2 inhibitor Vioxx "has galvanized opponents to a federal proposal that would relax some restrictions on drug promotion" in the U.S.
It's better to induce than to watch and wait. That's the result of a new study published in PLOS ONE.
Christopher A. Holden, President and Chief Executive Officer of AmSurg Corp., today announced financial results for the second quarter ended June 30, 2012. Revenues for the quarter were $231.6 million, a 23% increase from $187.5 million for the second quarter of 2011.
› Verified 6 days ago
| Entity Name | John Muir Magnetic Imaging Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235184110 PECOS PAC ID: 9032019625 Enrollment ID: O20040110000222 |
News Archive
Calls for the British Government to take action on TB have been met by a wall of silence from the Department of Health. The British Thoracic Society, the British Lung Foundation and TB Alert are warning that lives are being put at risk by the Government's failure to publish the long-promised TB Action Plan.
The New York Times on Saturday examined how a recent report indicating that Merck used "ghostwriters" to produce medical journal articles in support of the COX-2 inhibitor Vioxx "has galvanized opponents to a federal proposal that would relax some restrictions on drug promotion" in the U.S.
It's better to induce than to watch and wait. That's the result of a new study published in PLOS ONE.
Christopher A. Holden, President and Chief Executive Officer of AmSurg Corp., today announced financial results for the second quarter ended June 30, 2012. Revenues for the quarter were $231.6 million, a 23% increase from $187.5 million for the second quarter of 2011.
› Verified 6 days ago
| Entity Name | Solano Diagnostics Partners, A Calif Limited Partnership |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811940661 PECOS PAC ID: 4587556865 Enrollment ID: O20040330000319 |
News Archive
Calls for the British Government to take action on TB have been met by a wall of silence from the Department of Health. The British Thoracic Society, the British Lung Foundation and TB Alert are warning that lives are being put at risk by the Government's failure to publish the long-promised TB Action Plan.
The New York Times on Saturday examined how a recent report indicating that Merck used "ghostwriters" to produce medical journal articles in support of the COX-2 inhibitor Vioxx "has galvanized opponents to a federal proposal that would relax some restrictions on drug promotion" in the U.S.
It's better to induce than to watch and wait. That's the result of a new study published in PLOS ONE.
Christopher A. Holden, President and Chief Executive Officer of AmSurg Corp., today announced financial results for the second quarter ended June 30, 2012. Revenues for the quarter were $231.6 million, a 23% increase from $187.5 million for the second quarter of 2011.
› Verified 6 days ago
| Entity Name | John Muir Trauma Physicians Billing Service |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093864837 PECOS PAC ID: 3476542515 Enrollment ID: O20050420001452 |
News Archive
Calls for the British Government to take action on TB have been met by a wall of silence from the Department of Health. The British Thoracic Society, the British Lung Foundation and TB Alert are warning that lives are being put at risk by the Government's failure to publish the long-promised TB Action Plan.
The New York Times on Saturday examined how a recent report indicating that Merck used "ghostwriters" to produce medical journal articles in support of the COX-2 inhibitor Vioxx "has galvanized opponents to a federal proposal that would relax some restrictions on drug promotion" in the U.S.
It's better to induce than to watch and wait. That's the result of a new study published in PLOS ONE.
Christopher A. Holden, President and Chief Executive Officer of AmSurg Corp., today announced financial results for the second quarter ended June 30, 2012. Revenues for the quarter were $231.6 million, a 23% increase from $187.5 million for the second quarter of 2011.
› Verified 6 days ago
| Entity Name | Magnetic Imaging Affiliates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487040770 PECOS PAC ID: 5496066961 Enrollment ID: O20150624002629 |
News Archive
Calls for the British Government to take action on TB have been met by a wall of silence from the Department of Health. The British Thoracic Society, the British Lung Foundation and TB Alert are warning that lives are being put at risk by the Government's failure to publish the long-promised TB Action Plan.
The New York Times on Saturday examined how a recent report indicating that Merck used "ghostwriters" to produce medical journal articles in support of the COX-2 inhibitor Vioxx "has galvanized opponents to a federal proposal that would relax some restrictions on drug promotion" in the U.S.
It's better to induce than to watch and wait. That's the result of a new study published in PLOS ONE.
Christopher A. Holden, President and Chief Executive Officer of AmSurg Corp., today announced financial results for the second quarter ended June 30, 2012. Revenues for the quarter were $231.6 million, a 23% increase from $187.5 million for the second quarter of 2011.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chul Young Chung, MD 8181 Fannin St, Apt#2434, Houston, TX 77054-2911 Ph: (832) 283-2296 | Chul Young Chung, MD 1400 Locust St, Pittsburgh, PA 15219-5114 Ph: (412) 232-5689 |
News Archive
Calls for the British Government to take action on TB have been met by a wall of silence from the Department of Health. The British Thoracic Society, the British Lung Foundation and TB Alert are warning that lives are being put at risk by the Government's failure to publish the long-promised TB Action Plan.
The New York Times on Saturday examined how a recent report indicating that Merck used "ghostwriters" to produce medical journal articles in support of the COX-2 inhibitor Vioxx "has galvanized opponents to a federal proposal that would relax some restrictions on drug promotion" in the U.S.
It's better to induce than to watch and wait. That's the result of a new study published in PLOS ONE.
Christopher A. Holden, President and Chief Executive Officer of AmSurg Corp., today announced financial results for the second quarter ended June 30, 2012. Revenues for the quarter were $231.6 million, a 23% increase from $187.5 million for the second quarter of 2011.
› Verified 6 days ago
Dr. Matthew Scott Hartman, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 320 E North Ave, Pittsburgh, PA 15212 Phone: 412-359-2459 | |
Azza Elgendy, Radiology Medicare: Accepting Medicare Assignments Practice Location: 203 Lothrop St Ste 700, Pittsburgh, PA 15213 Phone: 412-864-8904 | |
Colin E. Champ, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4800 Friendship Ave Ste Gr508, Pittsburgh, PA 15224 Phone: 412-578-1923 Fax: 412-578-1936 | |
Gabin Yun, Radiology Medicare: Accepting Medicare Assignments Practice Location: 200 Lothrop St # E204, Pittsburgh, PA 15213 Phone: 412-647-7288 Fax: 412-647-2601 | |
Amisha Shah, Radiology Medicare: Accepting Medicare Assignments Practice Location: 3705 5th Ave, Chp Mt 3950, Pittsburgh, PA 15213 Phone: 412-647-2273 | |
Dr. Jennifer Pielstick Montgomery, MD, PHD Radiology Medicare: Accepting Medicare Assignments Practice Location: 200 Lothrop St, Suite 3950, Pittsburgh, PA 15213 Phone: 412-647-9729 Fax: 412-802-8221 | |
Dr. Hector Avelino Chamorro, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 995 Greentree Rd, Pittsburgh, PA 15220 Phone: 412-922-0100 |